-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Lumos Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Lumos Pharma, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$7.82M, a 18.9% increase year-over-year.
- Lumos Pharma, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$37.6M, a 10.4% decline year-over-year.
- Lumos Pharma, Inc. annual Operating Income (Loss) for 2023 was -$36.6M, a 14.3% decline from 2022.
- Lumos Pharma, Inc. annual Operating Income (Loss) for 2022 was -$32M, a 2.21% decline from 2021.
- Lumos Pharma, Inc. annual Operating Income (Loss) for 2021 was -$31.3M, a 19.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)